Gilead Sciences Inc.

08/15/2022 | Press release | Distributed by Public on 08/15/2022 06:38

Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in the TROPiCS-02 Study